Born on February 19, 1975 in Nalchik, KBR.
Graduated from the Faculty of Biology, Lomonosov Moscow State University in 1998.
D. in Biology (2013), Professor of the Russian Academy of Sciences, Head of the Department of Metabolism and Redox Biology of the Institute of Biochemistry of the Russian Academy of Sciences, Professor at the University of Göttingen.
Vsevolod Belousov is a scientist known in Russia and worldwide, a specialist in synthetic biology, molecular neurotechnology, and biomedicine. Biosensor and bioengineering technologies developed by Vsevolod Belousov are used by hundreds of laboratories worldwide. One of the main areas of Belousov's research is thermogenetics: controlling the activity of neurons and other cells by means of temperature-sensitive ion channels. Thermogenetic technologies are being developed to activate the brain, heart and pancreas. Another area of research is metabolic engineering - creation of artificial metabolic pathways in cells. For the development of technology to manage oxidative stress at the subcellular level and its application to study the mechanisms of heart failure, Vsevolod Belousov was awarded the Discovery Award-2019 by the Society for Redox Biology and Medicine in the USA.
Since 2019, Vsevolod Belousov has headed the Federal Brain and Neurotechnology Center of the Federal Medical and Biological Agency of Russia, a flagship scientific-clinical center that conducts research on pathologies of the nervous system and provides high-tech medical care in the profiles of neurology, neurorehabilitation, and neurosurgery. In the first wave of the Covid-19 pandemic, the Center was converted to an infectious disease hospital to treat patients with the new coronavirus infection. Vsevolod Belousov was awarded the Silver Cross of the Federal Medical and Biological Agency of Russia for successful organization of the clinic's work during the pandemic.